SELECTED RECENT PUBLICATIONS
The Division of Alcoholism and Drug Abuse

         Listed below are selected publications by Divisional faculty which appeared, or are in press, in the last three years.  They are selected from those which have a substance abuse focus.

Almoguera-Abad A, Castaneda R, Decastro A, Trujillo M: Superior efficacy of olanzepine in Chinese schizophrenic patients: results of an open laber study. Am J Psychiatry, in press

Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, Creticos C, Orozco-Cronin P, Popovia V, Mastro TD: for the VISION/VAX004 Study Team. HIV sexual risk behavior over 36-months of follow-up in the world’s first HIV vaccine efficacy trail. J Acq Immune Deficiency Syndr, in press

Basavarajappa BS, Saito M, Cooper TB and Hungund BL. Role of the endocannabinoid system in the development of tolerance to alcohol. Alcohol and Alcoholism (40):15-24, 2005.

Brodie JD, Figueroa E, Dewey SL: Treating cocaine addiction: from preclinical to clinical trial experience with γ-vinyl GABA. Synapse 50:261-265, 2003

Brodie JD, Figueroa E, Laska EM, Dewey SL. Safety and efficacy of gamma-vinyl GABA (GVG) for treatment of methamphetamine and/or cocaine addiction. Synapse 55:122-125, 2005

Brook DW, Brook JS, Rubenstone E, Zhang C, Singer M, Duke MR: Alcohol use in adolescents whose fathers abuse drugs. J Addict Dis 22:11-34, 2003

Brook DW, Brook JS, Rosen Z, De La Rosa M, Montoya ID, Whiteman M: Early risk factors for violence in Colombian adolescents. Am J Psychiatry. 160:1470-1478, 2003

Brook DW: Group and family therapy of substance abuse. In Gabbard G (Ed.) Treatment of DSM-IV Psychiatry Disorders. Arlington, VA: American Psychiatric Press, in press

Brook DW, Brook JS, Rubenstone E, Zhang C and Gerochi C: Cigarette smoking in the adolescent children of drug-abusing fathers. Pediatrics, in press

Brook DW, Brook JS, Rubenstone E, Zhang C and Rosen Z: Aggressive behaviors in the adolescent children of HIV-positive and HIV-negative drug-abusing fathers. Am J Drug and Alcohol Abuse, in press

Brook DW and Spitz HI: Group therapy of substance abuse. In Textbook of Adolescent Addiction of the American Society of Adolescent Psychiatry. Oxford, UK: Oxford University Press, in press

Brook JS: Tobacco use as a predictor of illicit drug use and drug-related problems in Colombian youth. J Adolesc Health 32:50-57, 2003

Brook JS, Brook DW, Rosen Z and Rabbitt CR: Earlier marijuana use and later problem behavior in Colombian youth. J Am Acad Child Adolescent Psych, 42(4):485-492, 2003

Brook JS, Brook DW, Richter L and Whiteman M: Risk and protective factors of adolescent drug use: Implications for prevention program. In Z Sloboda and WJ Bukoski (eds.), Handbook of Drug Abuse Prevention: Theory, Science and Practice: 265-287, New York: Plenum, 2003

Brook JS, Adams RE, Balka EB, Whiteman M, Zhang C and Sugerman R: Illicit drug use and risky sexual behavior among African American and Puerto Rican urban adolescents. The longitudinal links. J Genetic Psycho, 65(2):203-220, 2004

Brook JS, Brook DW, Schuster E, and Zhang C: Cigarette smoking and depressing symptoms: A longitudinal study of adolescents and young adults. Psycho Reports 95:159-166, 2004

Brook JS, Brook DW, Zhang C, and Cohen P. Tobacco use and health in young adulthood. J Genetic Psycho, 165(3):310-323, 2004

Brook JS, Pahl K, Balka EB, Fei K: Smoking among New Yorican adolescent: Time 1 predictors of Time 2 tobacco use. J Genetic Psycho, 165(3):324-340, 2004

Brook JS, Balka EB, Rosen Z, Brook DW and Adams R: Tobacco use in adolescent: The longitudinal links Illicit drug use and risky sexual behavior among African American and Puerto Rican urban adolescents. J Genetic Psycho, 165(2):203-220, 2004

Brook JS, Morojele N, Brook DW and Rosen Z: Predictors of cigarettes use among South African adolescents Intl J Behavioral Med 12(4):207-217, 2005

Brook JS, Pahl K. The protective role of ethnic and racial identity and aspects of an Africentric orientation against drug use among African-American young adults. J Genetic Psycho 166(3): 329-345, 2005

Brook JS, Balka EB, Fei K, and Whiteman M: The effects of parental tobacco and marijuana use and personality attributes on child rearing in African-American and Puerto Rican young adults. J Child Family Studies, in press

Brook JS, DW, Pahl K. The developmental contexts for adolescent substance abuse intervention. In H.a. Liddle (ed.). Adolescent substance abuse: Intervention and Management: Treatment Adolescent Substance Abuse: State of the Art Science, Cambridge University Press, in press

Brook JS, Morojele N, and Pahl K: Predictors of drug use among South African adolescents. J Adolescent Health, in press

Brown RL, Marcus MT, Straussner SLA, Graham AV, Madden T, Schoener E, Henry R. Pilot test of a national dissemination model to enhance substance abuse curriculum at health professions schools: Findings from Project Mainstream’s first fellowship cohort. Health Education Journal, in press

Carr KD, Tsimberg Y, Berman Y, Yamamoto N: Evidence of increased dopamine receptor signaling in food-restricted rats. Neuroscience 119:1157-1167, 2003

Casadonte P: Impact of the FDA LAAM labeling warning on a VA narcotic treatment program in New York City. Drug Alcohol Depend 66:27, 2002

DeLaRosa M, Holleran L and Straussner SLA (eds.) Substance abusing Latinos: Current research on epidemiology, prevention and treatment. New York: Haworth Press, 2005

De Leon G, Jones HE and Stitzer M: Medication free treatment of opioid dependence in (E.C. Strain and M.L. Stitzer (Eds.) The Treatment of Opioid Dependence, Baltimore, MD: Johns Hopkins University Press: 323-245, 2005

De Leon G: The addiction therapeutic communities for psychiatric disorders. Therapeutic communities, Silver Jubilee Edition, 26(4):405-422, 2005

De Leon G: Modified therapeutic communities for co-occurring substance abuse and psychiatric disorders. In R. Stohler and W. Rossler (Eds.), Dual diagnosis. The evolving conceptual framework, Bibliotheca Psychiatrica 172:137-156. Basel, Switzerland: S. Karger AG, 2004

DeLeon G: Therapeutic communities. In M Galanter and HD Kleber (Eds.), American Psychiatric Publishing Textbook of Substance Abuse (3rd Edition):485-502. Washington, DC: American Psychiatric Publishing, 2004

DeLeon. Therapeutic communities: research-practice reciprocity. In J.L. Sorensen, R.A. Rawson, J. Guydish & J.E. Zweben (Eds.), Drug abuse treatment through collaboration: practice and research partnerships that work. Washington, DC, American Psychological Association, pp. 17-35, 2003

De Leon G. The research context for therapeutic communities in the USA. In J. Lees, N. Making, D. Menzies, and N. Morant (Eds.), Research therapeutic communities. London, Jessica Kingley Publishers, 2003

DeLeon G: Integrating maintenance and different therapeutic programming.  In H. Waal and E. Haga (Eds.) Maintenance treatment of heroin addiction: Evidence at the crossroads: 296-314. Oslo, Norway: J.W. Cappelen Akademisk Forlag, 2003

DeLeon G: Therapeutic community and methadone maintenance (Passages). In H. Waal and E. Haga (Eds.) Maintenance treatment of heroin addiction: Evidence at the crossroads: 315-320. Oslo, Norway: J.W. Cappelen Akademisk Forlag, 2003

Dermatis H, Galanter M, Trujillo M, Rahman-Dujarris C, Ramaglia K, LaGressa D: Evaluation of a model for the treatment of combined mental illness and substance abuse: The Bellevue model for peer-led treatment in systems change. J Addic Dis, in press

Dermatis H, Guschwan M, Galanter M, Bunt G: Orientation toward spirituality and self-help approaches in the therapeutic community. J Addict Dis, in press

Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, Cheever LW, Cargill VA. Overcoming barriers to prevention, care and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases 40:S266-285, 2005

Fishbein DA, Lo Y, Reinus JF, Gourevitch MN, Klein RS. Factors associated with successful referral for clinic care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr 37:1367-1375, 2004

Fu SS, Sherman SE, Joseph Am, van Ryn M, Lanto AB, Joseph AM. Ethnic disparities in the use of pharmacotherapy for smoking cessation in an equal access health care system. Am J Health Prom 20:108-116, 2005

Galanter M: Spirituality in Alcoholic Anonymous: A valuable adjunct to psychiatric services. Psych Services 57(3):307-309, 2006

Galanter M, Forest J: Cult mentality in relation to terrorist behavior. In The Making of a Terrorist, Vol. II, Forest JJF (ed.) Westport CT: Praeger Publishers 51-70, 2005

Galanter M, Hayden F, Castaneda R: Group therapy, self-help groups, and network therapy. In Clinical Textbook of Addictive Disorders, 3rd edition. Frances RJ, Miller SI, Mach AH (eds.). New York: The Guilford Press, 2005

Galanter M (Ed): Recent Developments in Alcoholism, Vol. XVII. Alcohol problems in adolescent and young adults drinking. New York: Kluwer/Plenum Press, 2005 (Re-released in 2005 by Springer Publishing)

Galanter M: Spirituality and Addiction: A research and clinical perspective. Am J Addictions, in press

Galanter M, Dermatis H, Glickman L, Maslansky R, Sellers B, Neuman E and Rahman-Dujarric C: Network therapy: Decreased secondary opioid use during buprenorphine maintenance. J Substance Abuse Treatment 26:313-318, 2004

Galanter M, Kleber HK (eds.): Textbook of Substance Abuse Treatment, 3rd Edition. Washington DC: American Psychiatric Publishing, 2004

Galanter M, Dermatis H, Resnick RB, Maslansky R, Neuman E: Short term buprenorphine maintenance: treatment outcome. J Addict Dis 22:39-49, 2003

Glazer SS, Galanter M, Megwinoff O, Dermatis H, Keller DS: The role of therapeutic alliance in network therapy, a family and peer support-based treatment for cocaine abuse. Subst Abus 24:93-200, 2003

Glickman L, Galanter M, Dermatis H, Dingle S, Hall L: Pathways to recovery: Adapting 12-step recovery to methadone treatment. J Maintenance in Addictions 2:77-90, 2005

Grodzicki J, Galanter M: Spirituality and addiction. Substance Abuse, in press

Halkitis PN, Zade D, Zhrem M, Marmor M: Beliefs about HIV non-infection and risky sexual behavior among MSM. AIDS Education and Prevention 16:448-458, 2004

Harro CD, Judson FN, Gorse GJ, Mayer KH, Kostman JR, Brown SJ, Koblin B, Marmor M, Bartholow BN, Popovic V for the VAS004 Study Group: Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trail. J Acq Immune Deficiency Syndr 37:1385-1392, 2004

Hawke JM, Jainchill J, De Leon G: Post-treatment victimization and violence among adolescents following residential drug treatment. Child Maltreatment 8:58-71, 2003

Hopper K, Barrow. Two genealogies of supported housing: implications for outcome assessment. Psychiatr Serv 54:50-54, 2003

Hopper K. Reckoning with homelessness. Ithaca, Cornell University Press, 2003

Howard AA, Arnsten JH, Gourevitch MN: Effect of alcohol consumption and drug abuse on diabetes mellitus: A systematic review. Annals Intl Med 140:211-219, 2004

Hungund BL, Szakall I, Adam A, Basavarajappa BS, and Vadasz C: Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 84:698-704, 2003

Hungund BL and Basavarajappa BS: Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors. Ann NY Acad Sci 1025:515-527, 2004

Isralowitz R, Straussner S, Rosenblum A. Drug abuse, risks of infectious diseases and service utilization among former Soviet Union immigrants: A view from New York City. J Ethnicity in Substance Abuse, in press

Isralowitz R, Straussner SLA, Vogt I, Chtenguelov V. Preliminary exploration of immigrant substance abusers from the former Soviet Union living in Israel, Germany and the United States: A multi-national perspective. J social Work Practice in the addictions 2(3/4), 2003

Kaufman E, Brook DW. Family Therapy: Other Drugs. In M Galanter, HD Kleber (Eds.) Textbook of Substance Abuse Treatment, Third Edition. Washington, DC, American Psychiatric Press, 2004

Karasz A, Zallman L, Berg KM, Gourevitch MN, Selwyn P, Arnsten J: The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain System Management 28:517-525, 2004

Kovacs KM, Szakall I, O’Brien D, Wang R, Vinod KY, Saito M, Simonin F, Kieffer BL, Vadasz C: Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res 29:730-737, 2005

Krystal AD, Walsh JK, Laska E, Caron J, Amato Da, Wessel TC, Roth T: Sustained efficacy eszopiclone over 6 months of nightly treatment: Results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 1:793-799, 2003

Laska EM, Leber P: If placebo works, could, should or would it be approved for marketing? Chance 15, 2002

Lee J, Vlahov D, Freudenberg N: Factors associated with primary care utilization and health insurance among women released from jail. J Health Care Poor and Underserved, in press

Lee S, Galanter M, Dermatis H, McDowell D: Circuit parties and patterns of drug use in a subset of gay men. J Addict Dis 24:47-60, 2003

Levounis P and Ruggiero JS: Outpatient management of crystal methamphetamine dependence among gay and bisexual men: How can it be done? Primary Psychiatry 13(2), 2006

Ma L, Marmor M, Zhong P, Zekeng L, Su B, Nyambi P: Distribution of CCR2-641 and SDF-1- 3’A alleles and HIV status in 7 ethnic populations of Cameroon. J Acq Immune Deficiency Syndr 40:89-95, 2005

Marcus MT, Brown RL, Straussner SLA, Schoener E, Henry R, Graham AV, Madden T, Saundera LA. Creating change agents: A national substance abuse education project. Substance Abuse, in press

Marmor M, Penn A, Widmer K, Levin RI, Maslansky R: Coronary artery disease and opioid use. Amer J Cardiol 93:1295-1297, 2004

Maslansky R: A prisoner with acute renal failure. Lancet 363(9419):1474, 2004

Minerly ACE, Nazarian A, Russo SJ, Kemen LM, Akhavan A, Jenab S, Quinones-Jenab V: Chronic exogenous testosterone administration does not affect cocaine-induced conditioned place preference in male rats, in preparation

Minerly ACE, Nazarian A, Russo SJ, Kemen LM, Nazarian A, Wu HBK, Akhavan A, Jenab S, Quinones-Jenab V: Acute and chronic testosterone replacement does not alter cocaine-induced conditioned place preference and locomotor activation in male rats, in preparation

Minerly ACE, Wu HBK, Weierstall KM, Niyomchai T, Jenab S, Quinones-Jenab V: Effects of testosterone on cocaine-induced locomotor behavior: Adult vs. adolescent intake male Fischer rats, in preparation

Nadel M and Straussner SLA. Children in substance abusing families. In Phillips NK and Straussner SLA (eds.). Children in the urban environment: Linking social policy and Clinical practice (2nd Ed) New York: Haworth Press, 2006

Naegle MA: Necessary leaps for addictions nursing education and practice. Journal of Addictions Nursing 16:161-162, 2005

Naegle MA, Richardson H & Morton K: Rehab instead of prison: Drug courts provide opportunities for nurse practitioners. American Journal of Nursing 104:58-61, 2004

Naegle MA: A world view of nurses and midwives responding to alcohol, tobacco and other drug issues. The Drug and Alcohol Professional 3(4):31-39, 2003

Naegle M: Advanced practice psychiatric-mental health nursing. In M. Mezey, D. O’McGivern, W. Sullivan-Marx (Eds.) Nurse Practitioners: Evolution of Advanced Practice (4th ed.) New York: Springer Publishing Company, 2003

Nierenberg J, Hoptman MJ, Nash L, Ardekani BA, Bunt G, Lim KO, Rotrosen J: Reversible and long-term white matter changes in cocaine dependence, submitted

Nierenberg J, Nash L, Hoptman MJ, Hrabe J, Ardekani BA, Bunt G, Lim KO, Rotrosen J: White matter changes in cocaine dependence, Neuropsycho-pharmacology 30:S210, 2005

Nowak KL, Vinod KY and Hungund BL. Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol. Alcohol and Alcoholism 41:24-32, 2006

Onoprishvili I, Andria ML, Kramer HL, Ancevska-Taneva N, Hiller JM, Simon EJ. Interaction between the MU opioid receptor and filamin A is involved in receptor regulation and trafficking.  Mol Pharmacol 64:1092-1100, 2003

Pace N, Ketcham K. Teens under the influence: The truth about kids, alcohol and other drugs – How to recognize the problem and what to do about it.  Ballantine Books/Random House Publishing, 2003

Perez-Perez GI, Olivarea AZ, Foo FY, Neusy AJ, Ng C, Holzman RS, Foo S, Marmor M, Blaser MJ: Seroprevalance of helicobacter pylori in Asian-born populations in New York City. J Urban Hlth 82:510-516, 2005

Reid MS, Prichep L, Ciplet D, O’Leary S, Tom ML, Howard BS, Rotrosen J, John R: Quantitative electroencephalographic studies of cue-induced cocaine craving. Clin Electroencephalogr 34:110-123, 2003

Reid MS, Ciplet D, O’Leary S, Angrist B: Sensitization to the psychosis-inducing effects of cocaine compared with measure of cocaine craving and cue. Am J Addict, in press Resnick RB: Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction. Ann Internal Medicine 138:360, 2003

Ross S. Virtual mentor: Identifying an impaired physician. Ethics J Am Med Assoc 5(12), 2003

Ross S, Galanter M. Consultation-liaison psychiatry literature database (2003 update). Substance Abuse. General Hospital Psychiatry 25(6):464-465, 2003

Ross S. Alcohol use disorders: Special topics. Guest Editor’s Notes. Primary Psych 12(1):30-31, 2005

Ross S. Alcohol use disorders in the elderly. Primary Psych 12(1):32-40, 2005

Ross S, Hayden F. Self-assessment guide to textbook of substance abuse treatment, 3rd edition Galanter M and Kleber M (eds.). Published by the APA as an online publication, 2005

Ross W, Collins E, Galanter M. Substance abuse in the medically ill. To be published in Psychosomatic Medicine in the 21st Century, Blumenfled M, Strain J (eds.), Lippincott Williams and Wilkins, 2006

Rossi S, Singer S, Shearman E, Sershen H, and Lajtha A. Regional heterogeneity of nicotine effects on neurotransmitters in rat brain in vivo at low doses. Neurochem Res 30:91-109, 2005

Rossi S, Singer S, Shearman E, Sershen H, and Lajtha A. The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes. Neurochem Res 30:541-558, 2005

Russo SF, Sun W, Minerly ACE, Weierstall KM, Nazarian A, Festa ED, Niyomchai T, Akhavan A, Luine V, Jenab S, Quinones-Jenab V: Progesterone blocks acquisition and expression of cocaine reward but not locomotor responses in intact female rats, possibly through blocking spatial memory formation, in preparation

Sacks S, De Leon G, Sacks JY, McKendrick K, Brown B: TC-oriented supported housing for homeless MICAs. J Psychoactive Drugs 35(3), 2003

Saito M, O’Brien D, Kovacs KM, Wang R, Zavadil J, Vadasz C: Nicotine-induced sensitization in mice: Changes in locomotor activity and mesencephalic gene expression. Neurochem Res 30:1027-1035, 2005

Saito M, Saito M, Cooper TB, Vadasz C: Ethanol-induced changes in the content of triglycerides, ceramides, and glucosylceramides in cultured neurons. Alcohol Clin Exp Res 29:1374-1383, 2005

Saito M, Saito M, Cooper TB, Vadasz C: Alcohol reduces GM1 content in the serum of inbred mouse strains. Alcohol Clin Exp Res 28:1107-1113, 2005

Saito M, Szakall I, Toth R, Kovacs KM, Oros M, Prasad VTS, Blumerberg M, Vadasz C: Mouse straital transcriptome analysis: Effects of oral alcohol self-administration. Alcohol 32:223-241, 2004

Saito M, Ehringer MA, Toth R, Oros M, Szakall I, Sikela JM, Vadasz C: Variants of kappa opioid receptor gene and MRNA in alcohol-preferring and – avoiding mice. Alcohol 29:39-49, 2003

Shearman E, Rossi S, Sershen H, Hashim A and Lajtha A. A locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function. Neurochem Res 30:1055-1066, 2005

Sherman SE, Braslow J, Garcia D, Chapman A. Improving recognition of depression in primary care: A study of evidence-based quality improvement. Joint Commission J Qual Safety., 30:80-88, 2004

Sherman SE, Yano EM, Lanto AB, Simon BF, Rubinstein LV. Smokers’ interest in quitting and services received: Using practice information to plan quality improvement and policy for smoking cessation. Am J Med Qual, 20:33-39, 2005

Sherman SE, Fu SS, Joseph AM, Lanto AB, Yano EM. Gender differences in smoking cessation services received among veterans. Women’s Health Issues, 15:126-133, 2005

Sherman SE, Joseph AM, Yano EM, Simon BF, Arikian N, Parrkerton P, Rubenstein LV, and Mittman BS. Characteristics of VA facility smoking cessation programs and practices. Mil Medicine, in press

Sherman SE, Yano EM, Lanto AB, Cernof BA, Mittman BS. Assessing the structure of smoking cessation care in the Veterans Health Administration. Am J Health Prom, in press

Siegel C, Laska EM, Meisner M: Estimating capacity requirements for mental health services after a disaster has occurred: A call for new data. Am J Public Health, 582-585, 2004

Siegel C, Haugland G, David-Chambers E: Performance measures and their benchmarks for assessing organizational cultural competency in behavioral health care service delivery. Adm Policy Ment Health 141-170, 2003

Straussner SLA. Assessment and treatment of clients with alcohol and other drug abuse problems: An overview. In Straussner SLA (ed.). Clinical work with substance abusing clients (2nd Ed). New York: Guilford Press, 2004

Thakkar VG. Psychiatry. In Talreja DR, Talreja RR, Talreja RS (eds.) Internal medicine peripheral brain. New York: Lippincott, Williams, and Wilkins 807-832, 2005

Thakkar VG. Depression and bipolar disorder. New York: Lippincott, Williams, and Wilkins 807-832, 2005

Thakkar VG. Addictions. New York: Chelsea House, 2006

Tracy K, Weingarten R, Mattison E, Piselli A, Rounsaville B: Moving beyond illness to recovery: the recovery is for everyone grants program (RIFE). Psychiar Rehabil J 28(2):129-135, 2004

Vinod KY, Kassir SA, Basavarajappa BS, Yalamanchili R, Cooper TB, Mann JJ, Arango V and Hungund BL. Elevated levels of endocannabinoids, CB1 receptors and agonist-medicated G-protein signaling I the prefrontal cortex of alcoholic suicide victims. Biological Psychiatry (57):480-486, 2005

Weierstall KM, Niyomchai T, Wu HBK, Minerly ACE, Akhavan A, Weiner J, Sun W, Nazarian A, Jenab S, Quinones-Jenab V: The role of 5-HT and 5-HT 1B in cocaine-induced locomotor activity in in male and female rats, in preparation

Weiner J, Weierstall KM, Niyomchai T, Wu HBK, Minerly ACE, Kemen LM, Sun W, Festa ED, Jenab S, Quinones-Jenab V: Estrous cycle effects on cocaine-induced behavioral responses, in preparation

Wu HBK, Niyomchai T, Weierstall KM, Minerly ACE, Hunter D, Weiner J, Sun W, Zhou L, Jenab S, Quinones-Jenab V: Effects of progesterone and estrogen antagonists on cocaine-induced behavioral psychomotor responses, in preparation

Wu HBK, Niyomchai T, Minerly ACE, Weierstall KM, Hunter D, Sun W, Weiner J, Jenab S, Quinones-Jenab V: Effects of RU 486 and tamoxifen on cocaine-induced behavioral and endocrine activations in male and female Fischer rats, in press

Westreich L: Addiction and the Americans with disabilities act. J Am Acad Psychiatry Law 30:355-363, 2003